BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 15875150)

  • 1. Hemojuvelin: a supposed role in iron metabolism one year after its discovery.
    Celec P
    J Mol Med (Berl); 2005 Jul; 83(7):521-5. PubMed ID: 15875150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pathophysiology and genetics of classic HFE (type 1) hemochromatosis].
    Loréal O; Ropert M; Mosser A; Déhais V; Deugnier Y; David V; Brissot P; Jouanolle AM
    Presse Med; 2007 Sep; 36(9 Pt 2):1271-7. PubMed ID: 17521857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Non-HFE-related hereditary iron overload].
    Aguilar-Martinez P
    Presse Med; 2007 Sep; 36(9 Pt 2):1279-91. PubMed ID: 17540536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-HFE haemochromatosis.
    Wallace DF; Subramaniam VN
    World J Gastroenterol; 2007 Sep; 13(35):4690-8. PubMed ID: 17729390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic iron metabolism gene expression profiles in HFE associated hereditary hemochromatosis.
    Gleeson F; Ryan E; Barrett S; Russell J; Crowe J
    Blood Cells Mol Dis; 2007; 38(1):37-44. PubMed ID: 17098454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemochromatosis: genetics and pathophysiology.
    Beutler E
    Annu Rev Med; 2006; 57():331-47. PubMed ID: 16409153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repression of repulsive guidance molecule C during inflammation is independent of Hfe and involves tumor necrosis factor-alpha.
    Constante M; Wang D; Raymond VA; Bilodeau M; Santos MM
    Am J Pathol; 2007 Feb; 170(2):497-504. PubMed ID: 17255318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The iron driven pathway of hepcidin synthesis.
    Deugnier Y
    Gastroenterol Clin Biol; 2010; 34(6-7):351-4. PubMed ID: 20537480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differing impact of the deletion of hemochromatosis-associated molecules HFE and transferrin receptor-2 on the iron phenotype of mice lacking bone morphogenetic protein 6 or hemojuvelin.
    Latour C; Besson-Fournier C; Meynard D; Silvestri L; Gourbeyre O; Aguilar-Martinez P; Schmidt PJ; Fleming MD; Roth MP; Coppin H
    Hepatology; 2016 Jan; 63(1):126-37. PubMed ID: 26406355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemojuvelin: the hepcidin story continues.
    Malyszko J
    Kidney Blood Press Res; 2009; 32(2):71-6. PubMed ID: 19287179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hfe and Hjv exhibit overlapping functions for iron signaling to hepcidin.
    Kent P; Wilkinson N; Constante M; Fillebeen C; Gkouvatsos K; Wagner J; Buffler M; Becker C; Schümann K; Santos MM; Pantopoulos K
    J Mol Med (Berl); 2015 May; 93(5):489-98. PubMed ID: 25609138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron stores modulate hepatic hepcidin expression by an HFE-independent pathway.
    Gehrke SG; Herrmann T; Kulaksiz H; Merle U; Bents K; Kaiser I; Riedel HD; Stremmel W
    Digestion; 2005; 72(1):25-32. PubMed ID: 16103673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mechanisms of systemic iron homeostasis and etiology, diagnosis, and treatment of hereditary hemochromatosis.
    Kawabata H
    Int J Hematol; 2018 Jan; 107(1):31-43. PubMed ID: 29134618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iron disorders of genetic origin: a changing world.
    Brissot P; Bardou-Jacquet E; Jouanolle AM; Loréal O
    Trends Mol Med; 2011 Dec; 17(12):707-13. PubMed ID: 21862411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-HFE hepatic iron overload.
    Pietrangelo A; Caleffi A; Corradini E
    Semin Liver Dis; 2011 Aug; 31(3):302-18. PubMed ID: 21901660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-HFE hemochromatosis.
    Pietrangelo A
    Semin Liver Dis; 2005 Nov; 25(4):450-60. PubMed ID: 16315138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble hemojuvelin is released by proprotein convertase-mediated cleavage at a conserved polybasic RNRR site.
    Lin L; Nemeth E; Goodnough JB; Thapa DR; Gabayan V; Ganz T
    Blood Cells Mol Dis; 2008; 40(1):122-31. PubMed ID: 17869549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Competitive regulation of hepcidin mRNA by soluble and cell-associated hemojuvelin.
    Lin L; Goldberg YP; Ganz T
    Blood; 2005 Oct; 106(8):2884-9. PubMed ID: 15998830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conditional disruption of mouse HFE2 gene: maintenance of systemic iron homeostasis requires hepatic but not skeletal muscle hemojuvelin.
    Gkouvatsos K; Wagner J; Papanikolaou G; Sebastiani G; Pantopoulos K
    Hepatology; 2011 Nov; 54(5):1800-7. PubMed ID: 21748766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of disease: The role of hepcidin in iron homeostasis--implications for hemochromatosis and other disorders.
    Pietrangelo A; Trautwein C
    Nat Clin Pract Gastroenterol Hepatol; 2004 Nov; 1(1):39-45. PubMed ID: 16265043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.